Samsung Biologics Announces KRW 3 Trillion Rights Offering to Fund Its Next-Phase Expansion

Samsung Biologics to raise $2.17 bil. via rights offering - The Korea Times

Samsung Biologics announced Friday it would raise 3 trillion won ($2.17 billion) through a rights offering as part of efforts to fund investments i...